NLRP3 and Parkinson disease: Major findings of the present study gave proof of the systemic inhibition by MSCs of NLRP3 and the other two molecules, caspase-1 and IL-1β, of the inflammasome in the brain (specifically the midbrain), liver, and gut in PD mice.